Evidence map›Paper›PMID 26777758›Full record

ArticleJournal of cardiac failure2016

Serum Bicarbonate in Acute Heart Failure: Relationship to Treatment Strategies and Clinical Outcomes.

Lauren B Cooper, Robert J Mentz, Dianne Gallup, Anuradha Lala, Adam D DeVore, Justin M Vader, Omar F AbouEzzeddine, Bradley A Bart, Kevin J Anstrom, Adrian F Hernandez and 1 more

Abstract readComparative Study
In one paragraph

Article in Journal of cardiac failure, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Targeting Sodium in Heart Failure.Journal of personalized medicine · 2024
    Review
  6. Article
  7. Article
  8. Serum Chloride and Heart Failure.Kidney medicine · 2023
    Review
  9. Review
  10. Review
  11. Diuretic Treatment in Heart Failure.The New England journal of medicine · 2017
    Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Lauren B CooperDuke Clinical Research Institute, Durham, North Carolina. Electronic address: lauren.b.cooper@duke.edu.
Robert J MentzDuke Clinical Research Institute, Durham, North Carolina.
Dianne GallupDuke Clinical Research Institute, Durham, North Carolina.
Anuradha LalaBrigham and Women's Hospital, Boston, Massachusetts; Mount Sinai School of Medicine, New York, New York.
Adam D DeVoreDuke Clinical Research Institute, Durham, North Carolina.
Justin M VaderWashington University School of Medicine, St Louis, Missouri.
Omar F AbouEzzeddineMayo Clinic, Rochester, Minnesota.
Bradley A BartHennepin County Medical Center, Minneapolis, Minnesota.
Kevin J AnstromDuke Clinical Research Institute, Durham, North Carolina.
Adrian F HernandezDuke Clinical Research Institute, Durham, North Carolina.
G Michael FelkerDuke Clinical Research Institute, Durham, North Carolina.
Clinical Research Institute · USBrigham and Women's Hospital · USHennepin County Medical Center · USMayo Clinic · USWashington University in St. Louis · US

Funding

Postdoctoral Training in Cardiovascular Clinical ResearchT32HL069749 · NHLBI · DUKE UNIVERSITY · PI MARK, DANIEL B · 2003 to 2023
$6.7M
Heart Failure Clinical Research Network Regional Clinical Center (U10)U10HL110312 · NHLBI · DUKE UNIVERSITY · PI FELKER, GARY M · 2012 to 2018
$3.5M
NHLBI NIH HHS T32 HL069749NHLBI NIH HHS U10 HL110312
6 · The paper itself

Abstract

backgroundThough commonly noted in clinical practice, it is unknown if decongestion in acute heart failure (AHF) results in increased serum bicarbonate. METHODS AND

resultsFor 678 AHF patients in the DOSE-AHF, CARRESS-HF, and ROSE-AHF trials, we assessed change in bicarbonate (baseline to 72-96 hours) according to decongestion strategy, and the relationship between bicarbonate change and protocol-defined decongestion. Median baseline bicarbonate was 28 mEq/L. Patients with baseline bicarbonate ≥28 mEq/L had lower ejection fraction, worse renal function and higher N-terminal pro-B-type natriuretic peptide than those with baseline bicarbonate <28 mEq/L. There were no differences in bicarbonate change between treatment groups in DOSE-AHF or ROSE-AHF (all P > .1). In CARRESS-HF, bicarbonate increased with pharmacologic care but decreased with ultrafiltration (median +3.3 vs -0.9 mEq/L, respectively; P < .001). Bicarbonate change was not associated with successful decongestion (P > .2 for all trials).

conclusionsIn AHF, serum bicarbonate is most commonly elevated in patients with more severe heart failure. Despite being used in clinical practice as an indicator for decongestion, change in serum bicarbonate was not associated with significant decongestion.

Indexed as

Acute DiseaseAgedBicarbonatesBiomarkersChi-Square DistributionDisease ProgressionDiureticsFemaleHeart FailureHumansLinear ModelsMaleMiddle AgedPredictive Value of TestsPrognosisRandomized Controlled Trials as TopicBicarbonatesBiomarkersDiureticsDiureticsEdemaHeart failure

Identifiers

PMID26777758
PMCPMC4945480
OpenAlexW2238274268

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.